Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.415 USD | +6.39% | +76.83% | -78.00% |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 18-06-30 | |
Zdravka Medarova
FOU | Founder | 50 | 15-12-31 |
Susan Duggan
COO | Chief Operating Officer | - | - |
Alan Freidman
IRC | Investor Relations Contact | - | - |
Seth Gregg
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Magda Marquet
BRD | Director/Board Member | 65 | 20-12-31 |
Philippe Calais
CHM | Chairman | 65 | 18-09-30 |
Erik Manting
BRD | Director/Board Member | 53 | 20-12-19 |
Chief Executive Officer | 73 | 18-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,108,053 | 6,099,563 ( 99.86 %) | 0 | 99.86 % |
Company contact information
TransCode Therapeutics, Inc.
6 Liberty Square Suite 2382
02109, Boston
+
http://www.transcodetherapeutics.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.00% | 8.12M | |
+3.30% | 108B | |
+11.16% | 104B | |
+1.28% | 22.33B | |
-12.69% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.59% | 17.64B | |
+4.33% | 14.05B | |
+34.89% | 12.51B |
- Stock Market
- Equities
- RNAZ Stock
- Company TransCode Therapeutics, Inc.